These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16227634)

  • 1. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
    Cao D; Wilentz RE; Abbruzzese JL; Ho L; Maitra A
    Int J Gastrointest Cancer; 2005; 36(1):39-46. PubMed ID: 16227634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia.
    Lai KK; Horvath B; Xie H; Wu X; Lewis BL; Pai RK; Plesec T; Patil DT; Gordon IO; Wang Y; Shen B; Goldblum JR; Liu X
    Inflamm Bowel Dis; 2015 Feb; 21(2):378-84. PubMed ID: 25569733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
    Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
    Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease.
    Levi GS; Harpaz N
    Am J Surg Pathol; 2006 Aug; 30(8):1022-9. PubMed ID: 16861975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
    Gui X; Liu S; Yan Y; Gao Z
    World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
    Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
    Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
    B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
    Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.
    Deng L; Zhou JF; Sellers RS; Li JF; Nguyen AV; Wang Y; Orlofsky A; Liu Q; Hume DA; Pollard JW; Augenlicht L; Lin EY
    Am J Pathol; 2010 Feb; 176(2):952-67. PubMed ID: 20042677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions.
    Halliday G; Porter RJ; Black CJ; Arends MJ; Din S
    World J Gastroenterol; 2022 Apr; 28(13):1338-1346. PubMed ID: 35645542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of HNF4A and β-catenin expression to predict low-grade dysplasia in the colitis-neoplastic sequence.
    He Y; Chen L; Chen K; Sun Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):94-101. PubMed ID: 33300557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer.
    Sakurai T; Kashida H; Watanabe T; Hagiwara S; Mizushima T; Iijima H; Nishida N; Higashitsuji H; Fujita J; Kudo M
    Cancer Res; 2014 Nov; 74(21):6119-28. PubMed ID: 25187386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
    Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
    Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease.
    Wen KW; Umetsu SE; Goldblum JR; Gill RM; Kim GE; Joseph NM; Rabinovitch PS; Kakar S; Lauwers GY; Choi WT
    Histopathology; 2019 Oct; 75(4):578-588. PubMed ID: 31111543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms.
    Lv C; Zhao X; Gu H; Huang L; Zhou S; Zhi F
    Med Sci Monit; 2016 Dec; 22():4794-4802. PubMed ID: 27926694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia.
    Papadia C; Louwagie J; Del Rio P; Grooteclaes M; Coruzzi A; Montana C; Novelli M; Bordi C; de' Angelis GL; Bassett P; Bigley J; Warren B; Atkin W; Forbes A
    Inflamm Bowel Dis; 2014 Feb; 20(2):271-7. PubMed ID: 24280874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.